Indian Indices
Global Indices
Commodity (SPOT)
Currency (SPOT)
09 Dec 2016 | 11:34 PM
 

Dr. Reddy`s Laboratories Ltd. Share Price Live (BSE)
0

BSE Code: 500124 | NSE Symbol: DRREDDY
3,186.45
-13.75
(-0.42 %)
09 Dec 2016 | 03:43 PM
Change company
  • Open (Rs)
    3,191.00
  • Prev. close (Rs.)
    3,200.20
  • High (Rs.)
    3,215.00
  • Low (Rs.)
    3,170.00
  • 52W H (Rs.)
    3,664.00
  • 52W L (Rs.)
    2,750.00
  • Volume (Rs.)
    10810
  • MCap (Rs in Cr.)
    52,802.99
3188
-20.15
(-0.63 %)
  • Open (Rs)
    3,210.00
  • High (Rs)
    3,215.30
  • Low (Rs)
    3,168.80
  • Prev. close(Rs)
    3,208.15
  • Contracts Tra.
    2,48,000
  • Turnover (Cr.)
    79
  • Open Interest
    18,06,800
  • Open Int. chg
    34,600.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
126.10
Operating Margin (%)
24.97
Gross Profit Margin (%)
18.79
Net Profit Margin (%)
13.70
Total Debt/Equity
0.29
Dividend payout Ratio (Net Profit)
19.04
Earning Retention Ratio
84.32

News

05 Dec 2016 - 14:50:00-Dr Reddy's Laboratories Ltd today announced the launch of anti-fungal ointment nystatin and tria...
27 Oct 2016 - 09:24:00-Leading pharma company Dr. Reddy’s Laboratories Ltd...
25 Oct 2016 - 17:32:00-Country’s secong largest drug maker Dr Reddys Laboratories Ltd on Tuesday reported a significa...
13 Oct 2016 - 16:38:00-Dr Reddy's Laboratories said that it has launched Aripiprazole tablets used to treat certain men...

Announcements

05-Dec-2016
Dr. Reddy`s Labs - Allotment of Equity Shares on exercise of ESOP
05-Dec-2016
Dr. Reddy`s Labs - Dr. Reddy`s Laboratories announces the launch of Nystatin and Triamcinolone Acetonide Cream USP in the U.
16-Nov-2016
Dr. Reddy`s Labs - Grant of Stock Options
11-Nov-2016
Dr. Reddy`s Labs - Dr. Reddy`s Laboratories announces the launch of Raloxifene HCI Tablets USP in the U.S. Market
11-Nov-2016
Dr. Reddy`s Labs - Updates

Religare Research

08 Dec 2016 | 09:42 AM
• Gold rose from lows ahead of central bank meetings. • Oil prices fell on doubts output cut will en...
08 Dec 2016 | 07:00 AM
We have been maintaining our cautious stance on market and especially on the banking pack for last t...
07 Dec 2016 | 11:37 AM
Agri Technical report
07 Dec 2016 | 11:36 AM
Agri Fundamental report

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
6,06,851 261.11 23.26 0.22
6,06,851 261.11 170.16 0.20
6,06,851 261.11 176.05 0.20
6,06,851 261.11 39.27 0.20
6,00,000 258.16 380.58 0.11

Shareholding Pattern

       
Promotors26.68%
Mutual Funds/UTI2.75%
FI/Banks3.72%
Insurance3.72%
FII37.18%
Government0.00%
Others21.53%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
4,712.00(-0.54)
3280
 GlaxoSmithKline Pharmaceuticals Ltd.
2,746.90(0.52)
3317
 Ajanta Pharma Ltd.
1,875.00(-1.59)
3790
 Piramal Enterprises Ltd.
1,721.35(-0.63)
3356

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Dr. Reddy``s Laboratories Ltd.71.650.2053.85
NIFTY(S&P CNX)-281.80-690.75-11.30
BSE SENSEX-843.96-2,298.10-273.48
BSE 500-417.92-846.62318.58

Corporate Details

Key Personal
Bharat Doshi
Addnl.Independent Director
G V Prasad
Co-Chairman & Manag. Director
Hans Peter Hasler
Addnl.Independent Director
Key Address
Registered Office
8-2-337 Road No. 3 Banjara Hills,Hyderabad,Telangana

Tel:040-49002900, Fax:040-49002999

shares@drreddys.com
http://www.drreddys.com
Registrar Office
Bigshare Services Pvt. Ltd.
Add. :E-2 & 3 Ansa Industrial Estate Saki-Vihar Road Sakinaka Andheri East

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Dr. Reddy`s Laboratories Ltd. that will help you decide whether to buy, sell or hold Dr. Reddy`s Laboratories Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Dr. Reddy`s Laboratories Ltd.

Regenerate OTP
Thank You for your interest in Religare Online. Our Representative will get in touch with you shortly.